-
Labcorp CEO Says Covid Vaccine Recipients Don't Need to Be Tested for Antibodies Afterward
“We still have to understand a lot more about the vaccines, know what to measure, how to measure,” LabCorp CEO Adam Schechter told CNBC.
-
Operation Warp Speed Chief Resigns at Biden Team's Request, Will Stay Through Transition, Sources Say
The scientific leader of the U.S. vaccine effort will stay in the role for 30 days, but won’t be chief advisor as of Inauguration Day, sources say.
-
Pfizer CEO Supports Expanding Covid Vaccine Eligibility, Describes Supply of Doses as Adequate
“I think the main bottleneck right now is to make sure we ramp up our prioritization so we can administer more vaccines,” Pfizer CEO Albert Bourla told CNBC.
-
Dr. Scott Gottlieb Expects Covid Vaccine Eligibility to Be Expanded Sooner Than Expected
“I think by the end of February, we’re going to find that we have to open up eligibility pretty wide,” Dr. Scott Gottlieb told CNBC.
-
Israel's Covid Vaccine Rollout Is the Fastest in the World — Here Are Some Lessons for the Rest of Us
From logistics to public information campaigns, there are a number of lessons that other countries could learn from Israel as they try to ramp up their own vaccination drives.
-
1 in 30 Londoners Has Covid as City Mayor Declares a Major Incident
London Mayor Sadiq Khan on Friday declared a major incident over the rapid spread of the coronavirus in the U.K.’s capital city.
-
Pfizer-BioNTech Vaccine Appears to Neutralize a Key Mutation of Covid Variants Found in UK, South Africa
The research, which has not yet been peer-reviewed, suggested the Pfizer-BioNTech vaccine worked to neutralize the so-called N501Y mutation.
-
Dr. Gottlieb Sees 30% of People in U.S. Getting Covid and 10% Vaccinated as of End of January
“You’re starting to get to levels of prior exposure in the population where the virus isn’t going to spread as readily,” Dr. Scott Gottlieb told CNBC.
-
WHO Warns of Tipping Point in Covid Pandemic, Says Europe Likely Seeing ‘Most Acute' Phase of Virus Spread
Countries are scrambling to contain two variants found in the U.K. and South Africa that are significantly more transmissible.
-
Why the U.S. Covid Vaccine Rollout Is Going More Slowly Than Planned: CNBC After Hours
On today’s show, CNBC’s Meg Tirrell explains where the U.S. is in its effort to roll out the Covid vaccine.
-
Stocks Begin 2021 With a Sell-Off, Dow Drops More Than 300 Points
Stocks dropped on Monday, the first trading day of 2021, amid concerns about global coronavirus cases and the Georgia runoff elections.
-
Dr. Scott Gottlieb: COVID Vaccine Eligibility Should Be Expanded Now to Deliver More Shots
“You need to stockpile something,” the former FDA chief told CNBC on Monday. “But putting away 50% of all the doses, I think, is denying more people access.”
-
U.S. Could Ramp Up Slow Covid Vaccine Rollout by Giving Two Half Volume Doses of Moderna Shot, Slaoui Says
Moncef Slaoui told CBS that Operation Warp Speed is looking at giving half doses of the Moderna vaccine to certain groups to speed up the Covid vaccine rollout.
-
Coronavirus Vaccines: Here's What You Need to Know
The vaccination of Americans against the coronavirus has begun, with medical workers, politicians and senior citizens among the first to receive one of two vaccines that have gotten emergency approval in the United States: Pfizer-BioNTech and Moderna. A third vaccine, from AstraZeneca-Oxford, has won emergency approval in the United Kingdom, though results from its trials have raised questions about how…
-
Fauci Warns of Post-Christmas Surge in Covid Infections
Fauci warns that coronavirus infections may get another boost as Americans flock together for Christmas and New Year’s celebrations.
-
S&P 500 Ekes Out a Small Gain for the Quiet Holiday Session
U.S. stocks rose slightly on Thursday as Wall Street tried to wrap up the holiday-shortened week on a high note.
-
Holiday Sales Have Been Hurt by Pressure on Shipping Networks, Says Fanatics Chairman
“As good as business is, it could have even been better,” Fanatics Executive Chairman Michael Rubin told CNBC.
-
WHO Chief Scientist Warns Against Covid Complacency, Says Herd Immunity Unlikely Until End-2021
The world has must be vigilant while the Covid vaccine is rolled out as it will take time for population immunity to be achieved, says Soumya Swaminathan from WHO.
-
West Virginia on Track to Deliver Covid Vaccines to All Its Nursing Homes by Year-End, Governor Says
West Virginia has leaned on local pharmacies to vaccinate its long-term care facility staff and residents, Gov. Jim Justice told CNBC.
-
‘I Just Don't Buy the Negativity' in Markets — Cramer Praises Covid Stimulus as Bridge to Vaccine
CNBC’s Jim Cramer called the recently approved coronavirus stimulus package “the $900 billion bridge” to a widely available Covid vaccine.